Sss Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 16-05-2024
- Paid Up Capital ₹ 5.49 Cr
as on 16-05-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.94 Cr
as on 16-05-2024
- Satisfied Charges ₹ 1.25 Cr
as on 16-05-2024
- Revenue 49.05%
(FY 2023)
- Profit 226.78%
(FY 2023)
- Ebitda 153.22%
(FY 2023)
- Net Worth 27.50%
(FY 2023)
- Total Assets 24.30%
(FY 2023)
About Sss Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.49 Cr.
The company currently has active open charges totaling ₹7.94 Cr. The company has closed loans amounting to ₹1.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pramod Banthiya, Priyanka Banthia, and Anil Baid serve as directors at the Company.
- CIN/LLPIN
U24233GJ2007PTC050232
- Company No.
050232
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sss Pharmachem Private Limited offer?
Sss Pharmachem Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Kitchen Cleaners, Common Disease Medicines, Antihistamines, Pharmaceutical Syrup, Animal Medicines & Health Care, Veterinary Injections, Sexual Wellness Products, Fertility Enhancer, Home Appliances & Kitchen Appliances.
Who are the key members and board of directors at Sss Pharmachem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Banthiya  | Director | 15-Mar-2007 | Current |
| Priyanka Banthia | Director | 22-Jul-2014 | Current |
| Anil Baid | Director | Current |
Financial Performance of Sss Pharmachem.
Sss Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.05% increase. The company also saw a substantial improvement in profitability, with a 226.78% increase in profit. The company's net worth Soared by an impressive increase of 27.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sss Pharmachem?
Unlock access to Sss Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 06 Nov 2023 | ₹4.50 Cr | Open |
Sidbi Creation Date: 10 Mar 2021 | ₹3.00 Cr | Open |
Sidbi Creation Date: 10 Apr 2020 | ₹4.40 M | Open |
How Many Employees Work at Sss Pharmachem?
Sss Pharmachem has a workforce of 49 employees as of May 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sss Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sss Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
